NCT00258544Active, not recruiting
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis
Source: ClinicalTrials.gov · Last updated 31 Aug 2026
Brief summary (registry, in English)
This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung may ultimately lead to new approaches to the diagnosis and treatment of pulmonary fibrosis.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 80 (actual)
- First submitted
- 23 Nov 2005
- Start date
- Oct 2001
- Primary completion date
- Jul 2030
- Lead sponsor
- University of Pittsburgh
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT00258544
What you commit to
- Study type: Observational
- Participants enrolled: 80
- From Oct 2001 to the primary completion date, Jul 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- N/A
Who the study is looking for
- 18 years or age or older
- Diagnosis of pulmonary fibrosis
- Undergoing open lung biopsy
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pittsburgh Coordinator of this site? Confirm its status | Pittsburgh | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.